Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Aquestive Therapeutics Second Quarter 2025 Earnings Conference Call.
Aquestive Therapeutics Inc. (AQST)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 2,979,840 | $9,863,270 | +1055% | 0% |
| 2. | Perceptive Advisors Joseph Edelman | 2,190,420 | $7,250,290 | -42% | 0.27% |
| 3. | Pale Fire Capital Dusan Senkypl, David Holy, And Jan Barta | 1,676,451 | $5,549,053 | +26% | 0.57% |
| 4. | Sio Capital Michael Castor | 947,489 | $3,136,189 | +142% | 1.2% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 551,700 | $1,826,127 | -5% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.81 | 5,000 | $4,050.00 | 59,532 | 2022-06-14 | Filing | |
| $0.96 | 91,743 | $88,073.28 | 193,702 | 2022-06-08 | Filing | |
| $0.96 | 45,871 | $44,036.16 | 882,871 | 2022-06-08 | Filing | |
| $0.96 | 2,293 | $2,201.28 | 54,532 | 2022-06-08 | Filing | |
| $0.96 | 13,761 | $13,210.56 | 38,761 | 2022-06-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.87 | 44 | $214.06 | 0 | 2024-11-26 | Filing | |
| $6.00 | 50,000 | $300,000.00 | 984,476 | 2024-03-15 | Filing | |
| $5.19 | 25,000 | $129,685.00 | 1,040,371 | 2024-03-08 | Filing | |
| $6.75 | 23,460 | $158,355.00 | 837,000 | 2021-02-10 | Filing | |
| $6.75 | 11,540 | $77,895.00 | 860,460 | 2021-02-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,810,958 | $32,474,271 | 100% | |
| 2. | 6,476,606 | $21,437,566 | 0% | |
| 3. | 4,328,505 | $14,327,352 | 0% | |
| 4. | 1,977,001 | $6,544,870 | 0% | |
| 5. | 1,507,298 | $4,989,156 | 0% |
News See All
H.C. Wainwright Reaffirms Buy on Aquestive Therapeutics, Inc. (AQST) After FDA Approval
Aquestive Therapeutics, Inc. (NASDAQ:AQST) is among the best growth stocks to invest in for the next 5 years. Analysts at H.C.
15 Best Growth Stocks to Invest in for the Next 5 Years
Before making any decision, whether big or small, we instinctively weigh its long-term impact, and this is particularly true in the case of stocks.
13 Best Multibagger Stocks to Invest in Now
The global economic and geopolitical environment in 2025 is marked by uncertainty, trade tensions, and shifting monetary policies.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Aquestive Therapeutics First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Fourth Quarter 2024 Aquestive Therapeutics Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Best Multibagger Stocks To Buy Heading into 2025
November has been an eventful month so far for the market as the Fed cut rates by a quarter percentage and president-elect, Donald Trump won the election for the second time.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Aquestive Therapeutics Third Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Aquestive Therapeutics Second Quarter 2024 Conference Call. [Operator Instructions] As a reminder, this call will be recorded.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Aquestive Therapeutics First Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
